Table of Content


Introduction
Uterine Leiomyoma (Uterine Fibroids) - Overview
Uterine Leiomyoma (Uterine Fibroids) - Therapeutics Development
Uterine Leiomyoma (Uterine Fibroids) - Therapeutics Assessment
Uterine Leiomyoma (Uterine Fibroids) - Companies Involved in Therapeutics Development
Uterine Leiomyoma (Uterine Fibroids) - Drug Profiles
Uterine Leiomyoma (Uterine Fibroids) - Dormant Projects
Uterine Leiomyoma (Uterine Fibroids) - Discontinued Products
Uterine Leiomyoma (Uterine Fibroids) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Uterine Leiomyoma (Uterine Fibroids), 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021


List of Tables


Number of Products under Development for Uterine Leiomyoma (Uterine Fibroids), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by AbbVie Inc, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Auritec Pharmaceuticals Inc, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Bayer AG, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Context Therapeutics LLC, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Endo International Plc, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Eurofarma Laboratorios SA, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Evestra Inc, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by GeneScience Pharmaceuticals Co Ltd, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Immunitor Inc, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Kissei Pharmaceutical Co Ltd, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Livzon Pharmaceutical Group Co Ltd, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Luye Pharma Group Ltd, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Richter Gedeon Nyrt, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
Uterine Leiomyoma (Uterine Fibroids) - Pipeline by TiumBio Co Ltd, 2021
Uterine Leiomyoma (Uterine Fibroids) - Dormant Projects, 2021
Uterine Leiomyoma (Uterine Fibroids) - Dormant Projects, 2021 (Contd..1)
Uterine Leiomyoma (Uterine Fibroids) - Discontinued Products, 2021